RESTRUX Trademark

Trademark Overview


On Tuesday, November 10, 2020, a trademark application was filed for RESTRUX with the United States Patent and Trademark Office. The USPTO has given the RESTRUX trademark a serial number of 90309240. The federal status of this trademark filing is REGISTERED as of Tuesday, January 4, 2022. This trademark is owned by Corelink, LLC. The RESTRUX trademark is filed in the Pharmaceutical Products category with the following description:

Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
restrux

General Information


Serial Number90309240
Word MarkRESTRUX
Filing DateTuesday, November 10, 2020
Status700 - REGISTERED
Status DateTuesday, January 4, 2022
Registration Number6609723
Registration DateTuesday, January 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements


Goods and ServicesHuman cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Pseudo MarkRESTRUCT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 8, 2021
Primary Code005
First Use Anywhere DateMonday, September 20, 2021
First Use In Commerce DateMonday, September 20, 2021

Trademark Owner History


Party NameCorelink, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSt. Louis, MO 63026

Party NameCorelink, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSt. Louis, MO 63026

Party NameCorelink, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Louis, MO 63026

Trademark Events


Event DateEvent Description
Tuesday, January 4, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, December 2, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 1, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 19, 2021USE AMENDMENT FILED
Friday, November 5, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 19, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 21, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, April 21, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 21, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, April 21, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 21, 2021NON-FINAL ACTION E-MAILED
Wednesday, April 21, 2021NON-FINAL ACTION WRITTEN
Monday, April 19, 2021ASSIGNED TO EXAMINER
Friday, January 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 13, 2020NEW APPLICATION ENTERED IN TRAM